$45,106,864

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

healthexpiredONGOING · MOD OF 2025 CONTRACT

WORK BEGAN2025-01-30·LATEST ACTION2026-03-27·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50325F80003_7505_36F79723D0219_3600

Award description

OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Procurement of oseltamivir phosphate (Tamiflu) capsules for federal pandemic preparedness and emergency response stockpiles.

Sub-sectors

pandemic-preparednessantiviral-stockpilepublic-health-emergency

Why this matters

Ensures U.S. government maintains strategic antiviral reserves for influenza pandemic response and public health emergencies.

Supply-chain signal

Large-scale procurement signals government confidence in Genentech's manufacturing capacity and supply chain for critical antivirals.

U.S.–China competition angle

Securing domestic antiviral production capacity reduces reliance on foreign pharmaceutical supply chains during health emergencies.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002208.

Period of performance

Start

2025-01-30

End

2025-06-06

Status

expired347 days ago

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50325F80003_7505_36F79723D0219_3600.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.